Farallon Capital Management LLC Surface Oncology, Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $2.27 Million - $3.79 Million	-479,979 Reduced 48.0%	520,021 $2.49 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $6.87 Million - $10.5 Million	1,000,000 New	1,000,000 $9.24 Million
Q3 2018 Nov 14, 2018	SELL	$8.92 - $17.83 $892,000 - $1.78 Million	-100,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$12.83 - $17.41 $1.28 Million - $1.74 Million	100,000 New	100,000 $1.63 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.